Questions remain around WA rollout of new flu vaccine

Key Points:

• Respiratory viruses, including flu and COVID-19, are increasing in the Seattle area as the new season approaches, with concerns heightened by ongoing misinformation and vaccine policy disputes led by Health Secretary Robert F. Kennedy Jr.
• A new mRNA-based flu vaccine, mFlusiva, approved for adults 50 and older, offers improved protection and faster development, but coverage by insurers is uncertain due to the vaccine advisory panel (ACIP) being nonfunctional amid legal challenges.
• The ACIP, responsible for vaccine recommendations, has been sidelined after Kennedy dismissed its expert members, leading to lawsuits and canceled meetings, creating uncertainty in official vaccine guidance and insurance coverage, particularly for Medicaid recipients.
• Washington state and the West Coast Health Alliance have issued their own vaccine recommendations, emphasizing COVID, flu, and RSV immunizations for all eligible groups, including healthcare workers, diverging from current CDC guidelines affected by litigation.
• Despite low vaccination rates last season, health officials urge the public to get vaccinated against respiratory viruses now, highlighting new vaccine advancements and rising respiratory illness cases in the region.